Elligo Health Research, Inc. operates in the clinical research space by engaging in health research and hiring specialized professionals.
Subscribe to see Elligo Health Research, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Elligo Health Research, Inc. is a pharma tech company headquartered in United States. It has raised at least $195.8M across the 6 funding rounds on record. Its most recent funding round, Debt, raised $14M in October 2023. Xcout tracks 15 named people at Elligo Health Research, Inc., including Barry Simms (Chief Executive Officer).
9 more named people on record for Elligo Health Research, Inc., with roles, board committees and tenure — see the full roster →
At least $195.8M raised across the 6 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Debt | $14M | 2 named | |
| Series E | $135M | 8 named | |
| SEC Form D filing | $20M | — | |
| — | $5.3M | 1 named | |
| SEC Form D filing | $16.2M | — | |
| SEC Form D filing | $5.3M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Elligo Health Research, Inc.'s closest competitors — see the full list of competitors and alternatives →
Circuit Clinical Solutions Inc. operates as an integrated research organization that connects patients, physicians, sponsors, and contract research organizations to facilitate clinical trials. The company provides end-to-end solutions including participant recruitment, trial enrollment, engagement, retention, and backend administrative support to help physicians conduct clinical research within their practices.
Cedar Health Research is a biotechnology and clinical research organization headquartered in Dallas, Texas. The company serves as a community research site network focused on advancing clinical trials and healthcare solutions.
RxE2 Inc. is a healthcare and pharmaceutical company that implements community-based decentralized clinical trials. It uniquely utilizes pharmacists as medication experts to drive clinical research outcomes. The company provides specialized platforms and services while managing patient data under established privacy frameworks.
Syneos Health is a biopharmaceutical solutions organization and contract research organization (CRO) that provides clinical development, regulatory, safety, and commercialization services. It serves biopharmaceutical and life sciences companies by offering clinical trials, consulting, marketing, and deployment solutions to help bring therapies to market.
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.
Evidenze is a contract research organization (CRO) that provides full-service clinical research, digital health solutions, and pharmacovigilance services. The company serves biotech and small-to-medium pharmaceutical companies by offering study start-up, clinical operations, data management, biostatistics, and medical writing services to accelerate clinical trials and optimize study outcomes.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Elligo Health Research, Inc.? Suggest a correction
Post the link and the card appears automatically — each network fetches the image itself.